Literature DB >> 2818209

Langerhans cells in vaccinia virus infection in mouse skin.

Y Becker1, E Sprecher.   

Abstract

Langerhans cells function as potent antigen-presenting cells in the epidermis. They were shown to play an essential role in the mechanisms of defense of the skin against viral infections. In the present study, the response of Langerhans cells to infection of the skin with vaccinia virus was investigated. Decrease in Langerhans cell density in the skin was accompanied by an increase in the pathogenicity of the WR and Noguchi but not of the Lister strain of vaccinia virus. Langerhans cell density was shown to increase rapidly at the site of inoculation with the two pathogenic strains of vaccinia virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818209     DOI: 10.1007/BF01317926

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  28 in total

1.  Langerhans cells at the sites of vaccinia virus inoculation.

Authors:  S Nagao; S Inaba; S Iijima
Journal:  Arch Dermatol Res       Date:  1976-07-26       Impact factor: 3.017

Review 2.  Role of epidermal Langerhans cells in viral infections.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Presence of Langerhans cells in the cornea of Klebsiella keratoconjunctivitis mice.

Authors:  E García-Olivares; B Carreras; J M Gallardo
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-01       Impact factor: 4.799

4.  Rifampicin and poxvirus replication.

Authors:  Z Ben-Ishai; E Heller; N Goldblum; Y Becker
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

5.  Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.

Authors:  R M Buller; G L Smith; K Cremer; A L Notkins; B Moss
Journal:  Nature       Date:  1985 Oct 31-Nov 6       Impact factor: 49.962

Review 6.  Antigen-presenting cells, including Langerhans cells, veiled cells and interdigitating cells.

Authors:  B M Balfour; H A Drexhage; E W Kamperdijk; E C Hoefsmit
Journal:  Ciba Found Symp       Date:  1981

7.  The effects of ultraviolet irradiation of the skin on herpes simplex virus infection: alteration in immune function mediated by epidermal cells and in the course of infection.

Authors:  T Otani; R Mori
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Expression of the HTLV-III envelope gene by a recombinant vaccinia virus.

Authors:  S Chakrabarti; M Robert-Guroff; F Wong-Staal; R C Gallo; B Moss
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

9.  Reduced Langerhans' cell Ia antigen and ATPase activity in patients with the acquired immunodeficiency syndrome.

Authors:  D V Belsito; M R Sanchez; R L Baer; F Valentine; G J Thorbecke
Journal:  N Engl J Med       Date:  1984-05-17       Impact factor: 91.245

10.  Vaccinia virus proteins on the plasma membranes of infected cells. II. Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells.

Authors:  V R Mallon; E A Domber; J A Holowczak
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

View more
  4 in total

Review 1.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 2.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Foot and mouth disease virus replication in bovine skin Langerhans cells under in vitro conditions detected by RT-PCR.

Authors:  D David; Y Stram; H Yadin; Z Trainin; Y Becker
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

4.  Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin.

Authors:  Kate Matthews; Cheng Mee Leong; Lindsay Baxter; Emma Inglis; Kankatsu Yun; B Thomas Bäckström; John Doorbar; Merilyn Hibma
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.